Proximal tubular cannabinoid-1 receptor regulates obesity-induced CKD

Journal of the American Society of Nephrology

Volumn 28, Issue 12, 2017, Pages 3518-3532

  Udi, Shiran ^a   Hinden, Liad ^a   Earley, Brian ^b   Drori, Adi ^a   Reuveni, Noa ^a   Hadar, Rivka ^a   Cinar, Resat ^b   Nemirovski, Alina ^a   Tam, Joseph ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; CANNABINOID 1 RECEPTOR; CARNITINE PALMITOYLTRANSFERASE I; CYCLIC AMP DEPENDENT PROTEIN KINASE; FATTY ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN KINASE LKB1; OXYGEN; PROTEIN SERINE THREONINE KINASE; STK11 PROTEIN, MOUSE;

AMPK SIGNALING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DIET INDUCED OBESITY; ENZYME ACTIVITY; FATTY ACID OXIDATION; GENE DELETION; KIDNEY DYSFUNCTION; KIDNEY FIBROSIS; KIDNEY INJURY; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; LEAN BODY WEIGHT; LIPID DIET; LIPID STORAGE; LIPOTOXICITY; MOLECULAR PATHOLOGY; MOUSE; NEPHRITIS; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; ANIMAL; BODY WEIGHT; C57BL MOUSE; CELL LINE; CHEMISTRY; COMPLICATION; FIBROSIS; GENE EXPRESSION REGULATION; GENETICS; GENOTYPE; HETEROZYGOTE; HUMAN; INFLAMMATION; MALE; METABOLISM; OBESITY; PATHOLOGY; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

ANIMALS; BODY WEIGHT; CELL LINE; FATTY ACIDS; FIBROSIS; GENE DELETION; GENE EXPRESSION REGULATION; GENOTYPE; HETEROZYGOTE; HUMANS; INFLAMMATION; KIDNEY FAILURE, CHRONIC; KIDNEY TUBULES, PROXIMAL; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OBESITY; OXYGEN; PROTEIN-SERINE-THREONINE KINASES; RECEPTOR, CANNABINOID, CB1; SIGNAL TRANSDUCTION;

EID: 85038413447     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2016101085     Document Type: Article

References (68)

1. Wang Y, Chen X, Song Y, Caballero B, Cheskin LJ: Association between obesity and kidney disease: A systematic review and meta-analysis. Kidney Int 73: 19-33, 2008
2. Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS: Bodymass index and risk for end-stage renal disease. Ann Intern Med 144: 21-28, 2006
3. Nguyen S, Hsu CY: Excess weight as a risk factor for kidney failure. Curr Opin Nephrol Hypertens 16: 71-76, 2007
4. Ejerblad E, Fored CM, Lindblad P, Fryzek J, McLaughlin JK, Nyrén O: Obesity and risk for chronic renal failure. J Am Soc Nephrol 17: 1695-1702, 2006
5. de Zeeuw D, Ramjit D, Zhang Z, Ribeiro AB, Kurokawa K, Lash JP, Chan J, Remuzzi G, Brenner BM, Shahinfar S: Renal risk and renoprotection among ethnic groups with type 2 diabetic nephropathy: A post hoc analysis of RENAAL. Kidney Int 69: 1675-1682, 2006
6. Remuzzi G, Macia M, Ruggenenti P: Prevention and treatment of diabetic renal disease in type 2 diabetes: The BENEDICT study. J AmSoc Nephrol 17[Suppl 2]: S90-S97, 2006
7. Deji N, Kume S, Araki S, Soumura M, Sugimoto T, Isshiki K, Chin-Kanasaki M, Sakaguchi M, Koya D, Haneda M, Kashiwagi A, Uzu T: Structural and functional changes in the kidneys of high-fat diet-induced obese mice. Am J Physiol Renal Physiol 296: F118-F126, 2009
8. Stemmer K, Perez-Tilve D, Ananthakrishnan G, Bort A, Seeley RJ, Tschöp MH, Dietrich DR, Pfluger PT: High-fat-diet-induced obesity causes an inflammatory and tumor-promotingmicroenvironment in the rat kidney. Dis Model Mech 5: 627-635, 2012
9. LeeW, Eom DW, Jung Y, Yamabe N, Lee S, Jeon Y, Hwang YR, Lee JH, KimYK, Kang KS, KimSN:Dendrobiummoniliforme attenuates high-fat diet-induced renal damage in mice through the regulation of lipidinduced oxidative stress. Am J Chin Med 40: 1217-1228, 2012
10. Pai R, Kirschenbaum MA, Kamanna VS: Low-density lipoprotein stimulates the expression of macrophage colony-stimulating factor in glomerular mesangial cells. Kidney Int 48: 1254-1262, 1995
11. Coimbra TM, Janssen U, Gröne HJ, Ostendorf T, Kunter U, Schmidt H, BrabantG, Floege J: Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes. Kidney Int 57: 167-182, 2000
12. Larrinaga G, Varona A, Pérez I, Sanz B, Ugalde A, Cándenas ML, Pinto FM, Gil J, López JI: Expression of cannabinoid receptors in human kidney. Histol Histopathol 25: 1133-1138, 2010
13. Tam J: The emerging role of the endocannabinoid system in the pathogenesis and treatment of kidney diseases. J Basic Clin Physiol Pharmacol 27: 267-276, 2016
14. Barutta F, Corbelli A, Mastrocola R, Gambino R, Di Marzo V, Pinach S, Rastaldi MP, Perin PC, Gruden G: Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy. Diabetes 59: 1046-1054, 2010
15. Nam DH, LeeMH, Kim JE, Song HK, Kang YS, Lee JE, Kim HW, Cha JJ, Hyun YY, Kim SH, Han SY, Han KH, Han JY, Cha DR: Blockade of cannabinoid receptor 1 improves insulin resistance, lipid metabolism, and diabetic nephropathy in db/db mice. Endocrinology 153: 1387-1396, 2012
16. Lim SK, Park SH: The high glucose-induced stimulation of B1R and B2R expression via CB(1)R activation is involved in rat podocyte apoptosis. Life Sci 91: 895-906, 2012
17. Lim JC, Lim SK, Park MJ, Kim GY, Han HJ, Park SH: Cannabinoid receptor 1 mediates high glucose-induced apoptosis via endoplasmic reticulum stress in primary cultured rat mesangial cells. Am J Physiol Renal Physiol 301: F179-F188, 2011
18. Lim JC, Lim SK, Han HJ, Park SH: Cannabinoid receptor 1 mediates palmitic acid-induced apoptosis via endoplasmic reticulum stress in human renal proximal tubular cells. J Cell Physiol 225: 654-663, 2010
19. Jenkin KA, McAinch AJ, Grinfeld E, Hryciw DH. Role for cannabinoid receptors in human proximal tubular hypertrophy. Cell Physiol Biochem 26: 879-886, 2010
20. Mukhopadhyay P, Pan H, Rajesh M, Bátkai S, Patel V, Harvey-White J, Mukhopadhyay B, Haskó G, Gao B, Mackie K, Pacher P: CB1 cannabinoid receptors promote oxidative/nitrosative stress, inflammation and cell death in a murine nephropathy model. Br J Pharmacol 160: 657-668, 2010
21. Janiak P, Poirier B, Bidouard JP, Cadrouvele C, Pierre F, Gouraud L, Barbosa I, Dedio J, Maffrand JP, Le Fur G, O'Connor S, Herbert JM: Blockade of cannabinoid CB1 receptors improves renal function, metabolic profile, and increased survival of obese Zucker rats. Kidney Int 72: 1345-1357, 2007
22. Jenkin KA, O'Keefe L, Simcocks AC, Grinfeld E, Mathai ML, McAinch AJ, Hryciw DH: Chronic administration of AM251 improves albuminuria and renal tubular structure in obese rats. J Endocrinol 225: 113-124, 2015
23. Barutta F, Grimaldi S, Gambino R, Vemuri K,Makriyannis A, Annaratone L, di Marzo V, Bruno G, Gruden G. Dual therapy targeting the endocannabinoid system prevents experimental diabetic nephropathy [published online ahead of print April 6, 2017]. Nephrol Dial Transplant doi:10.1093/ndt/gfx010
24. Mount P, Davies M, Choy SW, Cook N, Power D: Obesity-related chronic kidney disease-The role of lipid metabolism. Metabolites 5: 720-732, 2015
25. Declèves AE, Mathew AV, Cunard R, Sharma K: AMPK mediates the initiation of kidney disease induced by a high-fat diet. J Am Soc Nephrol 22: 1846-1855, 2011
26. Declèves AE, Zolkipli Z, Satriano J, Wang L, Nakayama T, Rogac M, Le TP, Nortier JL, FarquharMG, Naviaux RK, Sharma K: Regulation of lipid accumulation by AMP-activated kinase [corrected] in high fat dietinduced kidney injury. Kidney Int 85: 611-623, 2014
27. Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, Uchida S, Yamashita S, NodaM, Kita S, Ueki K, Eto K, Akanuma Y, Froguel P, Foufelle F, Ferre P, Carling D, Kimura S, Nagai R, Kahn BB, Kadowaki T: Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8: 1288-1295, 2002
28. Rubera I, Poujeol C, Bertin G, Hasseine L, Counillon L, Poujeol P, Tauc M: Specific Cre/Lox recombination in the mouse proximal tubule. J Am Soc Nephrol 15: 2050-2056, 2004
29. Szeto HH, Liu S, Soong Y, Alam N, Prusky GT, Seshan SV: Protection of mitochondria prevents high-fat diet-induced glomerulopathy and proximal tubular injury. Kidney Int 90: 997-1011, 2016
30. Tedesco L, Valerio A, CervinoC,CardileA, PaganoC, Vettor R, Pasquali R, Carruba MO, Marsicano G, Lutz B, Pagotto U, Nisoli E: Cannabinoid type 1 receptor blockade promotes mitochondrial biogenesis through endothelial nitric oxide synthase expression in white adipocytes. Diabetes 57: 2028-2036, 2008
31. Tedesco L, Valerio A, Dossena M, Cardile A, Ragni M, Pagano C, Pagotto U, Carruba MO, Vettor R, Nisoli E: Cannabinoid receptor stimulation impairs mitochondrial biogenesis in mouse white adipose tissue, muscle, and liver: The role of eNOS, p38 MAPK, and AMPK pathways. Diabetes 59: 2826-2836, 2010
32. Cavuoto P, McAinch AJ, Hatzinikolas G, Cameron-Smith D,Wittert GA: Effects of cannabinoid receptors on skeletal muscle oxidative pathways. Mol Cell Endocrinol 267: 63-69, 2007
33. Tam J, Cinar R, Liu J, Godlewski G, Wesley D, Jourdan T, Szanda G, Mukhopadhyay B, Chedester L, Liow JS, Innis RB, Cheng K, Rice KC, Deschamps JR, Chorvat RJ, McElroy JF, Kunos G: Peripheral cannabinoid-1 receptor inverse agonism reduces obesity by reversing leptin resistance. Cell Metab 16: 167-179, 2012
34. Long JZ, Nomura DK, Vann RE,Walentiny DM, Booker L, Jin X, Burston JJ, Sim-Selley LJ, Lichtman AH, Wiley JL, Cravatt BF: Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo. Proc Natl Acad Sci U S A 106: 20270-20275, 2009
35. Hawley SA, PanDA,Mustard KJ, Ross L, Bain J, EdelmanAM, Frenguelli BG, Hardie DG: Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab 2: 9-19, 2005
36. Shaw RJ, Kosmatka M, Bardeesy N, Hurley RL,Witters LA, DePinho RA, Cantley LC: The tumor suppressor LKB1 kinase directly activates AMPactivated kinase and regulates apoptosis in response to energy stress. Proc Natl Acad Sci U S A 101: 3329-3335, 2004
37. Wu HM, Yang YM, Kim SG: Rimonabant, a cannabinoid receptor type 1 inverse agonist, inhibits hepatocyte lipogenesis by activating liver kinase B1 and AMP-activated protein kinase axis downstream of Ga i/o inhibition. Mol Pharmacol 80: 859-869, 2011
38. Sabolic I, Vrhovac I, Eror DB, Gerasimova M, Rose M, Breljak D, Ljubojevic M, Brzica H, Sebastiani A, Thal SC, Sauvant C, Kipp H, Vallon V, Koepsell H: Expression of Na+-D-glucose cotransporter SGLT2 in rodents is kidney-specific and exhibits sex and species differences. Am J Physiol Cell Physiol 302: C1174-C1188, 2012
39. You G, LeeWS, Barros EJ, Kanai Y,Huo TL, Khawaja S,Wells RG,Nigam SK, Hediger MA: Molecular characteristics of Na(+)-coupled glucose transporters in adult and embryonic rat kidney. J Biol Chem 270: 29365-29371, 1995
40. Chen J, Williams S, Ho S, Loraine H, Hagan D, Whaley JM, Feder JN: Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members. Diabetes Ther 1: 57-92, 2010
41. Bonner C, Kerr-Conte J, Gmyr V, Queniat G, Moerman E, Thévenet J, Beaucamps C, Delalleau N, Popescu I,Malaisse WJ, Sener A, Deprez B, Abderrahmani A, Staels B, Pattou F: Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion. Nat Med 21: 512-517, 2015
42. Starowicz KM, Cristino L,Matias I,Capasso R, Racioppi A, Izzo AA,DiMarzo V: Endocannabinoid dysregulation in the pancreas and adipose tissue of mice fed with a high-fat diet. Obesity (Silver Spring) 16: 553-565, 2008
43. Malenczyk K, JazurekM, Keimpema E, Silvestri C, Janikiewicz J,Mackie K, Di Marzo V, Redowicz MJ, Harkany T, Dobrzyn A: CB1 cannabinoid receptors couple to focal adhesion kinase to control insulin release. J Biol Chem 288: 32685-32699, 2013
44. TharpWG, Lee YH,Maple RL, Pratley RE: The cannabinoid CB1 receptor is expressed in pancreatic delta-cells. Biochem Biophys Res Commun 372: 595-600, 2008
45. Li C, Bowe JE, Jones PM, Persaud SJ: Expression and function of cannabinoid receptors in mouse islets. Islets 2: 293-302, 2010
46. Avrahami D, Li C, Zhang J, Schug J, Avrahami R, Rao S, Stadler MB, Burger L, Schübeler D, Glaser B, Kaestner KH: Aging-dependent demethylation of regulatory elements correlates with chromatin state and improved b cell function. Cell Metab 22: 619-632, 2015
47. Ravinet Trillou C, Delgorge C, Menet C, Arnone M, Soubrié P: CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity. Int J Obes Relat Metab Disord 28: 640-648, 2004
48. Quarta C, Bellocchio L, Mancini G, Mazza R, Cervino C, Braulke LJ, Fekete C, Latorre R, Nanni C, Bucci M, Clemens LE, Heldmaier G, Watanabe M, Leste-Lassere T, Maitre M, Tedesco L, Fanelli F, Reuss S, Klaus S, Srivastava RK, Monory K, Valerio A, Grandis A, De Giorgio R, Pasquali R, Nisoli E, Cota D, Lutz B, Marsicano G, Pagotto U: CB(1) signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance. Cell Metab 11: 273-285, 2010
49. Jung KM, Clapper JR, Fu J, D'Agostino G, Guijarro A, Thongkham D, Avanesian A, Astarita G, DiPatrizio NV, Frontini A, Cinti S, Diano S, Piomelli D: 2-arachidonoylglycerol signaling in forebrain regulates systemic energy metabolism. Cell Metab 15: 299-310, 2012
50. Cardinal P, Bellocchio L, Guzmán-Quevedo O, André C, Clark S, ElieM, Leste-Lasserre T, Gonzales D, Cannich A,Marsicano G, Cota D: Cannabinoid type 1 (CB1) receptors on Sim1-expressing neurons regulate energy expenditure in male mice. Endocrinology 156: 411-418, 2015
51. Osei-Hyiaman D, Liu J, Zhou L, Godlewski G, Harvey-White J, Jeong WI, Bátkai S, MarsicanoG, Lutz B, Buettner C, KunosG:HepaticCB1 receptor is required for development of diet-induced steatosis, dyslipidemia, and insulin and leptin resistance in mice. J Clin Invest 118: 3160-3169, 2008
52. Jourdan T, Szanda G, Rosenberg AZ, Tam J, Earley BJ, Godlewski G, Cinar R, Liu Z, Liu J, Ju C, Pacher P, Kunos G:Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy. Proc Natl Acad Sci U S A 111: E5420-E5428, 2014
53. van der Heijden RA, Bijzet J, Meijers WC, Yakala GK, Kleemann R, Nguyen TQ, de Boer RA, Schalkwijk CG, Hazenberg BP, Tietge UJ, Heeringa P: Obesity-induced chronic inflammation in high fat diet challenged C57BL/6J mice is associated with acceleration of age-dependent renal amyloidosis. Sci Rep 5: 16474, 2015
54. Foster MC, Hwang SJ, Porter SA, Massaro JM, Hoffmann U, Fox CS: Fatty kidney, hypertension, and chronic kidney disease: The Framingham Heart Study. Hypertension 58: 784-790, 2011
55. Aliou Y, Liao MC, Zhao XP, Chang SY, Chenier I, Ingelfinger JR, Zhang SL: Post-weaning high-fat diet accelerates kidney injury, but not hypertension programmed by maternal diabetes. Pediatr Res 79: 416-424, 2016
56. Yokoyama M, Tanigawa K, Murata T, Kobayashi Y, Tada E, Suzuki I, Nakabou Y, Kuwahata M, Kido Y: Dietary polyunsaturated fatty acids slow the progression of diabetic nephropathy in streptozotocin-induced diabetic rats. Nutr Res 30: 217-225, 2010
57. Bonnet F, Deprele C, Sassolas A,Moulin P, Alamartine E, Berthezène F, Berthoux F: Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis. Am J Kidney Dis 37: 720-727, 2001
58. Rayner HC, Ward L, Walls J: Cholesterol feeding following unilateral nephrectomy in the rat leads to glomerular hypertrophy. Nephron 57: 453-459, 1991
59. Jenkin KA, McAinch AJ, Zhang Y, Kelly DJ, Hryciw DH: Elevated cannabinoid receptor 1 and G protein-coupled receptor 55 expression in proximal tubule cells and whole kidney exposed to diabetic conditions. Clin Exp Pharmacol Physiol 42: 256-262, 2015
60. Lecru L, Desterke C, Grassin-Delyle S, Chatziantoniou C, Vandermeersch S, Devocelle A, Vernochet A, Ivanovski N, Ledent C, Ferlicot S, Dalia M, Saïd M, Beaudreuil S, Charpentier B, Vazquez A, Giron-Michel J, Azzarone B, Durrbach A, François H: Cannabinoid receptor 1 is a major mediator of renal fibrosis. Kidney Int 88: 72-84, 2015
61. Murea M, FreedmanBI, Parks JS, Antinozzi PA, Elbein SC,Ma L: Lipotoxicity in diabetic nephropathy: The potential role of fatty acid oxidation. Clin J Am Soc Nephrol 5: 2373-2379, 2010
62. BuraczynskaM,Wacinski P, Zukowski P, DraganM, Ksiazek A: Common polymorphism in the cannabinoid type 1 receptor gene (CNR1) is associated with microvascular complications in type 2 diabetes. J Diabetes Complications 28: 35-39, 2014
63. Herman-Edelstein M, Scherzer P, Tobar A, Levi M, Gafter U: Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy. J Lipid Res 55: 561-572, 2014
64. Howlett AC: Pharmacology of cannabinoid receptors. Annu Rev Pharmacol Toxicol 35: 607-634, 1995
65. Han SH,Malaga-Dieguez L, Chinga F, KangHM, Tao J, Reidy K, Susztak K: Deletion of Lkb1 in renal tubular epithelial cells leads to CKD by altering metabolism. J Am Soc Nephrol 27: 439-453, 2016
66. Knani I, Earley BJ, Udi S, Nemirovski A, Hadar R, Gammal A, Cinar R, Hirsch HJ, Pollak Y, Gross I, Eldar-Geva T, Reyes-Capo DP, Han JC, Haqq AM, Gross-Tsur V, Wevrick R, Tam J: Targeting the endocannabinoid/ CB1 receptor system for treating obesity in Prader-Willi syndrome. Mol Metab 5: 1187-1199, 2016
67. Marsicano G, Wotjak CT, Azad SC, Bisogno T, Rammes G, Cascio MG, Hermann H, Tang J, Hofmann C, Zieglgänsberger W, Di Marzo V, Lutz B: The endogenous cannabinoid system controls extinction of aversive memories. Nature 418: 530-534, 2002
68. Chorvat RJ, Berbaum J, Seriacki K, McElroy JF: JD-5006 and JD-5037: Peripherally restricted (PR) cannabinoid-1 receptor blockers related to SLV-319 (Ibipinabant) as metabolic disorder therapeutics devoid of CNS liabilities. Bioorg Med Chem Lett 22: 6173-6180, 2012